Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Treasury Shares (2017 - 2023)

Historic Treasury Shares for Nephros (NEPH) over the last 6 years, with Q4 2023 value amounting to $42167.0.

  • Nephros' Treasury Shares rose 6268.13% to $42167.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $42167.0, marking a year-over-year increase of 6268.13%. This contributed to the annual value of $42167.0 for FY2023, which is 6268.13% up from last year.
  • As of Q4 2023, Nephros' Treasury Shares stood at $42167.0, which was up 6268.13% from $25920.0 recorded in Q4 2022.
  • Nephros' 5-year Treasury Shares high stood at $55.1 million for Q4 2019, and its period low was $25920.0 during Q4 2022.
  • Its 4-year average for Treasury Shares is $13.8 million, with a median of $50949.5 in 2021.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 11036502.31% in 2019, then plummeted by 5660.62% in 2022.
  • Over the past 4 years, Nephros' Treasury Shares (Quarter) stood at $55.1 million in 2019, then tumbled by 99.89% to $59732.0 in 2021, then plummeted by 56.61% to $25920.0 in 2022, then soared by 62.68% to $42167.0 in 2023.
  • Its last three reported values are $42167.0 in Q4 2023, $25920.0 for Q4 2022, and $59732.0 during Q4 2021.